Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Rationale for CD40 pathway blockade in autoimmune rheumatic disorders

30 Apr 2020

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chemokine receptors and signaling
Share to Immunotherapy and Immune Responses
Share to T-cell and B-cell Immunology

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 38273474
DOI: 10.1016/s2665-9913(20)30038-2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Rationale for CD40 pathway blockade in autoimmune rheumatic disordersPMID 38273474Read ↗

Modulation of NF-κB Signaling as a Therapeutic Target in AutoimmunitySemantic proximity Read ↗

Janus kinase inhibitors in autoimmune diseasesSemantic proximity Read ↗

Preclinical Inflammatory Rheumatic DiseasesSemantic proximity Read ↗

Immunogenetic implications in rheumatic diseases.Semantic proximity Read ↗

Macrophage CD40 signaling: A pivotal regulator of disease protection and pathogenesisSemantic proximity Read ↗

From phenotype to pathophysiology—placing rheumatic diseases in an immunological perspectiveSemantic proximity Read ↗

TNF ligands and receptors in autoimmunity: an updateSemantic proximity Read ↗

Potential role of soluble CD40 receptor in chronic inflammatory diseasesSemantic proximity Read ↗

Telitacicept: A novel horizon in targeting autoimmunity and rheumatic diseasesSemantic proximity Read ↗

Immunotherapy of rheumatic diseases based on understanding genetic predisposition to the development of these diseases.Semantic proximity Read ↗

The CD40/CD40L system: A new therapeutic target for diseaseSemantic proximity Read ↗

Mechanisms of Disease: the molecular and cellular basis of joint destruction in rheumatoid arthritisSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.